Industry Bulletins | November 9, 2021
BrainCheck Raises $10 Million In Series B Funding To Develop Its Cognitive Health Assessment & A Digital Therapeutic For Dementia Care
BrainCheck, a platform to detect and manage cognitive impairment, announced it raised $10 million in Series B funding. The funding round was led by Next Coast Ventures and S3 Ventures, with additional investors including Nueterra Capital, Tensility Ventures, and True Wealth Ventures. In addition, UPMC Enterprises and SelectQuote have joined as strategic investors. The round takes the total capital raised by BrainCheck to date to $20 million. BrainCheck intends to use the funding to expand its research and development capabilities, develop a digital therapeutic, and enhance its market capabilities.
BrainCheck is an FDA Class II Software as a Medical Device . . .